You are here » Home » Companies » Company Overview » Everest Organics Ltd

Everest Organics Ltd.

BSE: 524790 Sector: Health care
NSE: N.A. ISIN Code: INE334C01029
BSE LIVE 15:23 | 18 Aug 96.50 2.20
(2.33%)
OPEN

92.50

HIGH

96.50

LOW

92.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 92.50
PREVIOUS CLOSE 94.30
VOLUME 570
52-Week high 114.80
52-Week low 44.45
P/E 46.62
Mkt Cap.(Rs cr) 77
Buy Price 94.00
Buy Qty 102.00
Sell Price 96.50
Sell Qty 8.00
OPEN 92.50
CLOSE 94.30
VOLUME 570
52-Week high 114.80
52-Week low 44.45
P/E 46.62
Mkt Cap.(Rs cr) 77
Buy Price 94.00
Buy Qty 102.00
Sell Price 96.50
Sell Qty 8.00

Everest Organics Ltd. (EVERESTORGANICS) - Company History

Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.